Home / Healthcare/ WHO panel calls for registry of all human gene editing research

WHO panel calls for registry of all human gene editing research


Comments / {{hitsCtrl.values.hits}} Views / Thursday, 21 March 2019 01:40

Facebook

A logo is pictured on the World Health Organization (WHO) headquarters in Geneva, Switzerland - REUTERS

LONDON (Reuters): It would be irresponsible for any scientist to conduct human gene-editing studies in people, and a central registry of research plans should be set up to ensure transparency, World Health Organization experts said on Tuesday.

After its first two-day meeting in Geneva, the WHO panel of gene editing experts – which was established in December after a Chinese scientist said he had edited the genes of twin babies – said it had agreed a framework for setting future standards.

It said a central registry of all human genome editing research was needed “in order to create an open and transparent database of ongoing work”, and asked the WHO to start setting up such a registry immediately.

“The committee will develop essential tools and guidance for all those working on this new technology to ensure maximum benefit and minimal risk to human health,” Soumya Swamanathan, the WHO’s chief scientist, said in a statement.

A Chinese scientist last year claimed to have edited the genes of twin baby girls.

News of the births prompted global condemnation, in part because it raised the ethical spectre of so-called “designer babies” – in which embryos can be genetically modified to produce children with desirable traits.

Top scientists and ethicists from seven countries called last week for a global moratorium on gene editing of human eggs, sperm or embryos that would result in such genetically-altered babies – saying this “could have permanent and possibly harmful effects on the species”.

The WHO panel’s statement said any human gene editing work should be done for research only, should not be done in human clinical trials, and should be conducted transparently.

“It is irresponsible at this time for anyone to proceed with clinical applications of human germline genome editing.”

 

 


Share This Article

Facebook Twitter


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Will power cuts solve electricity crisis?

Tuesday, 23 April 2019

The country faced electricity power cuts, reminding citizens of early 1990s, which resulted in private power producers supplying electrical power with long-term power supply agreements. Today, most have completed their agreement period, but some were


Easter attack: Going beyond condemnation

Tuesday, 23 April 2019

Yesterday was Easter Sunday; 227 persons [at the time of writing] have been killed, and many times more injured. The primary targets were churches and international hotels. It seems clear that the extremist group ISIS (Islamic State of Iraq and Syria


Easter Sunday nightmare

Tuesday, 23 April 2019

This is the most important day of the year for Christians – the Peaceful Easter Sunday or Easter Day was shattered by deadly explosions in several Christian churches throughout the country; and we excoriate such hatred in our beloved country. We th


Poignant pondering on a patriarch

Monday, 22 April 2019

Almost five months have gone. It is with a profound sense of sadness that we experienced the demise of our veteran teacher, respected author, legal luminary, an accomplished ambassador, an eminent public servant and an amazing human being, Dr. Wickre


Columnists More